Show simple item record

A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions

dc.contributor.authorBurger, Emily A
dc.contributor.authorde Kok, Inge MCM
dc.contributor.authorO'Mahony, James F
dc.contributor.authorRebolj, Matejka
dc.contributor.authorJansen, Erik EL
dc.contributor.authorde Bondt, Daniel D
dc.contributor.authorKillen, James
dc.contributor.authorHanley, Sharon J
dc.contributor.authorCastanon, Alejandra
dc.contributor.authorRegan, Mary Caroline
dc.contributor.authorKim, Jane J
dc.contributor.authorCanfell, Karen
dc.contributor.authorSmith, Megan A
dc.date.accessioned2023-10-21T23:18:48Z
dc.date.available2023-10-21T23:18:48Z
dc.date.issued2022-10-12
dc.identifier226390383
dc.identifier9e45fed0-17b8-408e-9049-c381c3776687
dc.identifier85141476860
dc.identifier.citationBurger , E A , de Kok , I MCM , O'Mahony , J F , Rebolj , M , Jansen , E EL , de Bondt , D D , Killen , J , Hanley , S J , Castanon , A , Regan , M C , Kim , J J , Canfell , K & Smith , M A 2022 , ' A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions ' , eLife , vol. 11 , e81711 . https://doi.org/10.7554/eLife.81711en
dc.identifier.issn2050-084X
dc.identifier.otherRIS: urn:6007D983D78284CFC57C9F59F178C0AB
dc.identifier.otherORCID: /0000-0002-7554-004X/work/127304236
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19866
dc.descriptionAcknowledgements Emily A Burger receives salary support from the Norwegian Cancer Society (#198073), Megan A Smith receives salary support from the National Health and Medical Research Council, Australia (APP1159491) and Cancer Institute NSW (ECF181561). James O’Mahony is funded by Ireland’s Health Research Board (EIA2017054). Matejka Rebolj receives support from Public Health England, which provided funding for evaluation of various PHE projects; member of various PHE advisory groups for cervical screening; attended meetings with various HPV assay manufacturers; fee for lecture in the last four years from Hologic, paid to employer. Funding Funder Grant reference number Author National Cancer Institute U01CA199334 Jane J Kim Karen Canfell Inge MCM de Kok Cancer Research UK C8162/A27047 Matejka Rebolj Alejandra Castanon Norwegian Cancer Society #198073 Emily A Burger National Health and Medical Research Council, Australia APP1159491 Megan A Smith Cancer Institute NSW ECF181561 Megan A Smith Ireland’s Health Research Board EIA2017054 James F O'Mahony Public Health England Matejka Rebolj The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The contents are solely the responsibility of the authors and do not necessarily represent the officialen
dc.format.extent17
dc.format.extent500283
dc.language.isoeng
dc.relation.ispartofeLifeen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectcervical canceren
dc.subjectCOVID-19en
dc.subjectsimulation modelingen
dc.subjectCancer Research UKen
dc.subjectC8162/A27047en
dc.titleA model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptionsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.7554/eLife.81711
dc.identifier.vol11en


Files in this item

Thumbnail
Name:
Wang_etal_ISAT_Global_Fast_Non ...
Size:
1.614Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record